Urology Ultrasound Devices Market Size, Share & Trends Analysis Report By Type (Handheld, Compact), By Application (Diagnosis, Treatment Planning), By Disease, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,950	200 Pages	Grand View Research	January, 2025	GV19584260

Best Price Guarantee
Price	from $5,950
Length	200 Pages
Publisher	Grand View Research
Published Date	January, 2025
SKU	GV19584260

Table of Contents
Description

Urology Ultrasound Devices Market Trends

The global urology ultrasound devices market size was valued at USD 1.21 billion in 2024 and is expected to grow at a CAGR of 6.17% from 2025 to 2030. Major factors contributing to the industry growth include the rising prevalence of urological disorders like kidney stones and prostate cancer, technological advancements such as AI-enabled and portable ultrasound devices, and the aging population, which is more prone to urological conditions. These factors, coupled with increasing awareness and early detection efforts, are fueling the market's expansion.

Urology ultrasound systems are highly efficient as they provide a non-invasive, safe, and cost-effective method for diagnosing, monitoring, and guiding treatments for various urological conditions. They deliver real-time imaging, enabling accurate visualization of the kidneys, bladder, prostate, and other urological structures, which is essential for detecting issues like kidney stones, benign prostatic hyperplasia (BPH), and prostate cancer. Additionally, their portability and ease of use make them ideal for point-of-care diagnostics and outpatient settings, allowing for faster clinical decisions. Advanced features, such as Doppler imaging, 3D/4D capabilities, and AI integration, enhance diagnostic precision and enable detailed treatment planning. Furthermore, urology ultrasounds assist in guiding minimally invasive procedures like biopsies, catheter placements, and stone removal, ensuring greater accuracy and reducing the risk of complications. Their versatility also extends to post-surgical evaluations and monitoring of chronic urological conditions, making them indispensable tools in modern urology care.

The growing prevalence of urological conditions such as kidney stones, benign prostatic hyperplasia (BPH), prostate cancer, urinary tract infections (UTIs), and bladder dysfunction is further contributing to the market growth. These conditions are becoming increasingly common due to factors such as aging populations, sedentary lifestyles, dietary habits, and rising rates of obesity and diabetes. For instance, prostate cancer remains one of the most diagnosed cancers among men globally, while kidney stones affect millions annually, driving the demand for effective diagnostic and monitoring tools. The increasing burden of these conditions highlights the critical role of urology ultrasound systems in early detection, treatment planning, and follow-up care, thereby propelling market expansion.

Global Urology Ultrasound Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global urology ultrasound devices market report on the basis of type, application, disease, end-use, and region:

Type Outlook (Revenue, USD Million, 2018 - 2030)
Handheld
Compact
Cart/Trolley
Application Outlook (Revenue, USD Million, 2018 - 2030)
Diagnosis
Treatment Planning
Guidance for Procedures
Monitoring
Screening
Disease Outlook (Revenue, USD Million, 2018 - 2030)
Prostate Disorders
Kidney Disorders
Bladder Disorders
Testicular Disorders
Post-Surgical Evaluation
Other Disorders
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Specialty Clinics
Diagnostic Imaging Centers
Other End Users
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.2. Segment Definitions; 1.2.1. Type; 1.2.2. Application; 1.2.3. Disease; 1.2.4. End Use; 1.2.5. Regional scope; 1.2.6. Estimates and forecasts timeline; 1.3. Research Methodology; 1.4. Information Procurement; 1.4.1. Purchased database; 1.4.2. GVR’s internal database; 1.4.3. Secondary sources; 1.4.4. Primary research; 1.4.5. Details of primary research; 1.4.5.1. Data for primary interviews in North America; 1.4.5.2. Data for primary interviews in Europe; 1.4.5.3. Data for primary interviews in Asia Pacific; 1.4.5.4. Data for primary interviews in Latin America; 1.4.5.5. Data for Primary interviews in MEA; 1.5. Information or Data Analysis; 1.5.1. Data analysis models; 1.6. Market Formulation & Validation; 1.7. Model Details; 1.7.1. Commodity flow analysis (Model 1); 1.7.2. Approach 1: Commodity flow approach; 1.7.3. Volume price analysis (Model 2); 1.7.4. Approach 2: Volume price analysis; 1.8. List of Secondary Sources; 1.9. List of Primary Sources; 1.10. Objectives
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Type outlook; 2.2.2. Application outlook; 2.2.3. Disease outlook; 2.2.4. End use outlook; 2.2.5. Regional outlook; 2.3. Competitive Insights
Chapter 3. Urology Ultrasound Devices Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent market outlook; 3.1.2. Related/ancillary market outlook; 3.2. Market Dynamics; 3.2.1. Market driver analysis; 3.2.1.1. Increasing prevalence of urological disorders; 3.2.1.2. Growing demand for noninvasive diagnosis; 3.2.1.3. Rising geriatric population; 3.2.1.4. Advancements in technology; 3.2.2. Market restraint analysis; 3.2.2.1. High cost of advanced ultrasound systems; 3.2.2.2. Complex regulatory environment; 3.3. Urology Ultrasound Devices Market Analysis Tools; 3.3.1. Industry Analysis - Porter’s; 3.3.1.1. Supplier power; 3.3.1.2. Buyer power; 3.3.1.3. Substitution threat; 3.3.1.4. Threat of new entrant; 3.3.1.5. Competitive rivalry; 3.3.2. PESTEL Analysis; 3.3.2.1. Political landscape; 3.3.2.2. Technological landscape; 3.3.2.3. Economic landscape
Chapter 4. Urology Ultrasound Devices Market: Type Estimates & Trend Analysis: 4.1. Segment Dashboard; 4.2. Global Urology Ultrasound Type Market Movement Analysis; 4.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million); 4.4. Handheld; 4.4.1. Handheld market estimates and forecasts 2018 to 2030 (USD Million); 4.5. Compact; 4.5.1. Compact market estimates and forecasts 2018 to 2030 (USD Million); 4.6. Cart/Trolley; 4.6.1. Cart/trolley market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Urology Ultrasound Devices Market: Application Estimates & Trend Analysis: 5.1. Segment Dashboard; 5.2. Global Urology Ultrasound Application Market Movement Analysis; 5.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million); 5.4. Diagnosis; 5.4.1. Diagnosis market estimates and forecasts 2018 to 2030 (USD Million); 5.5. Treatment Planning; 5.5.1. Treatment planning market estimates and forecasts 2018 to 2030 (USD Million); 5.6. Guidance for procedures; 5.6.1. Guidance for procedures market estimates and forecasts 2018 to 2030 (USD Million); 5.7. Monitoring; 5.7.1. Monitoring market estimates and forecasts 2018 to 2030 (USD Million); 5.8. Screening; 5.8.1. Screening market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Urology Ultrasound Devices Market: Disease Estimates & Trend Analysis: 6.1. Segment Dashboard; 6.2. Global Urology Ultrasound Disease Market Movement Analysis; 6.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million); 6.4. Prostate Disorders; 6.4.1. Prostate disorders market estimates and forecasts 2018 to 2030 (USD Million); 6.5. Kidney Disorders; 6.5.1. Kidney disorders market estimates and forecasts 2018 to 2030 (USD Million); 6.6. Bladder Disorders; 6.6.1. Bladder disorders market estimates and forecasts 2018 to 2030 (USD Million); 6.7. Testicular Disorders; 6.7.1. Testicular disorders market estimates and forecasts 2018 to 2030 (USD Million); 6.8. Post-Surgical Evaluation; 6.8.1. Post-surgical evaluation market estimates and forecasts 2018 to 2030 (USD Million); 6.9. Other Disorders; 6.9.1. Other disorders market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Urology Ultrasound Devices Market: End Use Estimates & Trend Analysis: 7.1. Segment Dashboard; 7.2. Global Urology Ultrasound End Use Market Movement Analysis; 7.3. Global Urology Ultrasound Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million); 7.4. Hospitals & Specialty Clinics; 7.4.1. Hospitals & Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million); 7.5. Diagnostic Imaging Centers; 7.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million); 7.6. Other End Users; 7.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Urology Ultrasound Devices Market: Regional Estimates & Trend Analysis By Type, Application, Disease, End Use: 8.1. Regional Market Share Analysis, 2024 & 2030; 8.2. Regional Market Dashboard; 8.3. Global Regional Market Snapshot; 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:; 8.5. North America; 8.5.1. U.S.; 8.5.1.1. Key country dynamics; 8.5.1.2. Competitive scenario; 8.5.1.3. Regulatory framework; 8.5.1.4. Reimbursement structure; 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million); 8.5.2. Canada; 8.5.2.1. Key country dynamics; 8.5.2.2. Competitive scenario; 8.5.2.3. Regulatory framework; 8.5.2.4. Reimbursement structure; 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million); 8.5.3. Mexico; 8.5.3.1. Key country dynamics; 8.5.3.2. Competitive scenario; 8.5.3.3. Regulatory framework; 8.5.3.4. Reimbursement structure; 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million); 8.6. Europe; 8.6.1. UK; 8.6.1.1. Key country dynamics; 8.6.1.2. Competitive scenario; 8.6.1.3. Regulatory framework; 8.6.1.4. Reimbursement structure; 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million); 8.6.2. Germany; 8.6.2.1. Key country dynamics; 8.6.2.2. Competitive scenario; 8.6.2.3. Regulatory framework; 8.6.2.4. Reimbursement structure; 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million); 8.6.3. France; 8.6.3.1. Key country dynamics; 8.6.3.2. Competitive scenario; 8.6.3.3. Regulatory framework; 8.6.3.4. Reimbursement structure; 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million); 8.6.4. Italy; 8.6.4.1. Key country dynamics; 8.6.4.2. Competitive scenario; 8.6.4.3. Regulatory framework; 8.6.4.4. Reimbursement structure; 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million); 8.6.5. Spain; 8.6.5.1. Key country dynamics; 8.6.5.2. Competitive scenario; 8.6.5.3. Regulatory framework; 8.6.5.4. Reimbursement structure; 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million); 8.6.6. Norway; 8.6.6.1. Key country dynamics; 8.6.6.2. Competitive scenario; 8.6.6.3. Regulatory framework; 8.6.6.4. Reimbursement structure; 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million); 8.6.7. Sweden; 8.6.7.1. Key country dynamics; 8.6.7.2. Competitive scenario; 8.6.7.3. Regulatory framework; 8.6.7.4. Reimbursement structure; 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million); 8.6.8. Denmark; 8.6.8.1. Key country dynamics; 8.6.8.2. Competitive scenario; 8.6.8.3. Regulatory framework; 8.6.8.4. Reimbursement structure; 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million); 8.7. Asia Pacific; 8.7.1. Japan; 8.7.1.1. Key country dynamics; 8.7.1.2. Competitive scenario; 8.7.1.3. Regulatory framework; 8.7.1.4. Reimbursement structure; 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million); 8.7.2. China; 8.7.2.1. Key country dynamics; 8.7.2.2. Competitive scenario; 8.7.2.3. Regulatory framework; 8.7.2.4. Reimbursement structure; 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million); 8.7.3. India; 8.7.3.1. Key country dynamics; 8.7.3.2. Competitive scenario; 8.7.3.3. Regulatory framework; 8.7.3.4. Reimbursement structure; 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million); 8.7.4. Australia; 8.7.4.1. Key country dynamics; 8.7.4.2. Competitive scenario; 8.7.4.3. Regulatory framework; 8.7.4.4. Reimbursement structure; 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million); 8.7.5. South Korea; 8.7.5.1. Key country dynamics; 8.7.5.2. Competitive scenario; 8.7.5.3. Regulatory framework; 8.7.5.4. Reimbursement structure; 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million); 8.7.6. Thailand; 8.7.6.1. Key country dynamics; 8.7.6.2. Competitive scenario; 8.7.6.3. Regulatory framework; 8.7.6.4. Reimbursement structure; 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million); 8.8. Latin America; 8.8.1. Brazil; 8.8.1.1. Key country dynamics; 8.8.1.2. Competitive scenario; 8.8.1.3. Regulatory framework; 8.8.1.4. Reimbursement structure; 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million); 8.8.2. Argentina; 8.8.2.1. Key country dynamics; 8.8.2.2. Competitive scenario; 8.8.2.3. Regulatory framework; 8.8.2.4. Reimbursement structure; 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million); 8.9. MEA; 8.9.1. South Africa; 8.9.1.1. Key country dynamics; 8.9.1.2. Competitive scenario; 8.9.1.3. Regulatory framework; 8.9.1.4. Reimbursement structure; 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million); 8.9.2. Saudi Arabia; 8.9.2.1. Key country dynamics; 8.9.2.2. Competitive scenario; 8.9.2.3. Regulatory framework; 8.9.2.4. Reimbursement structure; 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million); 8.9.3. UAE; 8.9.3.1. Key country dynamics; 8.9.3.2. Competitive scenario; 8.9.3.3. Regulatory framework; 8.9.3.4. Reimbursement structure; 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million); 8.9.4. Kuwait; 8.9.4.1. Key country dynamics; 8.9.4.2. Competitive scenario; 8.9.4.3. Regulatory framework; 8.9.4.4. Reimbursement structure; 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape: 9.1. Recent Developments & Impact Analysis, By Key Market Participants; 9.2. Company/Competition Categorization; 9.3. Key company market share analysis, 2024; 9.4. Company Position Analysis; 9.5. Company Categorization (Emerging Players, Innovators and Leaders; 9.6. Company Profiles; 9.6.1. GE HealthCare; 9.6.1.1. Company overview; 9.6.1.2. Financial performance; 9.6.1.3. Product benchmarking; 9.6.1.4. Strategic initiatives; 9.6.2. Koninklijke Philips N.V.; 9.6.2.1. Company overview; 9.6.2.2. Financial performance; 9.6.2.3. Product benchmarking; 9.6.2.4. Strategic initiatives; 9.6.3. Siemens Healthineers AG; 9.6.3.1. Company overview; 9.6.3.2. Financial performance; 9.6.3.3. Product benchmarking; 9.6.3.4. Strategic initiatives; 9.6.4. Canon Medical Systems; 9.6.4.1. Company overview; 9.6.4.2. Financial performance; 9.6.4.3. Product benchmarking; 9.6.4.4. Strategic initiatives; 9.6.5. Mindray Medical International Limited; 9.6.5.1. Company overview; 9.6.5.2. Financial performance; 9.6.5.3. Product benchmarking; 9.6.5.4. Strategic initiatives; 9.6.6. Samsung Medison Co., Ltd.; 9.6.6.1. Company overview; 9.6.6.2. Financial performance; 9.6.6.3. Product benchmarking; 9.6.6.4. Strategic initiatives; 9.6.7. FUJIFILM SonoSite, Inc.; 9.6.7.1. Company overview; 9.6.7.2. Financial performance; 9.6.7.3. Product benchmarking; 9.6.7.4. Strategic initiatives; 9.6.8. Konica Minolta Inc.; 9.6.8.1. Company overview; 9.6.8.2. Financial performance; 9.6.8.3. Product benchmarking; 9.6.8.4. Strategic initiatives; 9.6.9. Esaote; 9.6.9.1. Company overview; 9.6.9.2. Financial performance; 9.6.9.3. Product benchmarking; 9.6.9.4. Strategic initiatives